Naringenin nanocrystals for improving anti-rheumatoid arthritis activity

Naringenin (NAR) is recognized for its anti-inflammatory activity. However, the clinical application of NAR is limited by low bioavailability, which is attributed to its poor aqueous solubility. In this study, we aimed to improve the therapeutic efficacy of NAR by formulating it into nanocrystals (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Guangshuai, Sun, Guangyuan, Guan, Haishan, Li, Mo, Liu, Yanhua, Tian, Baocheng, He, Zhonggui, Fu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740402/
https://www.ncbi.nlm.nih.gov/pubmed/35027956
http://dx.doi.org/10.1016/j.ajps.2021.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740402/
https://www.ncbi.nlm.nih.gov/pubmed/35027956
http://dx.doi.org/10.1016/j.ajps.2021.09.001

Ejemplares similares